chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Pain, Pyrexia
Clinical narrative: my left elbow seemed to lock up, joint was difficult to move and painful; my left elbow seemed to lock up, joint was difficult to move and painful; I experienced a moderate fever; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient). A 44-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW10201) via an unspecified route of administration, administered in Arm Left on 21Mar2021 15:30 (age at vaccination 44-years-old) as DOSE 1, SINGLE for COVID-19 immunisation at Pharmacy or Drug Store. Patient medical history included right knee injury (right knee injury and several bulged disk in back), several bulged disk in back (right knee injury and several bulged disk in back), chronic pain (this is why I am in (company name) marijuana program, for chronic pain), acid reflux (I have had one surgery about 15 years for acid reflux. No other chronic issues), surgery (I have had one surgery about 15 years for acid reflux), covid-19 from an unknown date and unknown if ongoing (If covid prior vaccination- Yes). No other chronic issues. No known allergies. Concomitant medications received within two weeks included loperamide hydrochloride (IMODIUM) and marijuana (MARIJUANA) taken for an unspecified indication, start and stop date were not reported. The patient did not received any other vaccines within four weeks of COVID vaccine. The patient experienced my left elbow seemed to lock up, joint was difficult to move and painful, i experienced a moderate fever, body aches and fatigue all from on 23Mar2021 03:00 AM. It was reported 48 hours after first vaccine on 21Mar2021 his left elbow seemed to lock up, joint was difficult to move and painful. He experienced a moderate fever, body aches and fatigue. He was uninsured, he does not have a doctor to go to. His elbows never healed. He has never had any issues with either elbow until the vaccine. No treatment received for the events. Patient did not tested for covid post vaccination. The patient underwent lab tests and procedures which included body temperature: moderate fever on 23Mar2021. The clinical outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site joint movement impairment
Clinical narrative: my left elbow seemed to lock up, joint was difficult to move and painful; my left elbow seemed to lock up, joint was difficult to move and painful; I experienced a moderate fever; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient). A 44-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW10201) via an unspecified route of administration, administered in Arm Left on 21Mar2021 15:30 (age at vaccination 44-years-old) as DOSE 1, SINGLE for COVID-19 immunisation at Pharmacy or Drug Store. Patient medical history included right knee injury (right knee injury and several bulged disk in back), several bulged disk in back (right knee injury and several bulged disk in back), chronic pain (this is why I am in (company name) marijuana program, for chronic pain), acid reflux (I have had one surgery about 15 years for acid reflux. No other chronic issues), surgery (I have had one surgery about 15 years for acid reflux), covid-19 from an unknown date and unknown if ongoing (If covid prior vaccination- Yes). No other chronic issues. No known allergies. Concomitant medications received within two weeks included loperamide hydrochloride (IMODIUM) and marijuana (MARIJUANA) taken for an unspecified indication, start and stop date were not reported. The patient did not received any other vaccines within four weeks of COVID vaccine. The patient experienced my left elbow seemed to lock up, joint was difficult to move and painful, i experienced a moderate fever, body aches and fatigue all from on 23Mar2021 03:00 AM. It was reported 48 hours after first vaccine on 21Mar2021 his left elbow seemed to lock up, joint was difficult to move and painful. He experienced a moderate fever, body aches and fatigue. He was uninsured, he does not have a doctor to go to. His elbows never healed. He has never had any issues with either elbow until the vaccine. No treatment received for the events. Patient did not tested for covid post vaccination. The patient underwent lab tests and procedures which included body temperature: moderate fever on 23Mar2021. The clinical outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Oral pain, Swollen tongue, Toothache
Clinical narrative: tongue became swollen; mouth inside is sore; teeth ache; This is a spontaneous report from a contactable consumer or other non hcp (Patient).     A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 12Apr2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced side effect from vaccine received last tuesday, a few days after tongue became swollen, entire mouth inside was sore but has no sores and experienced teeth ache. The patient took Benadryl and it reduced the swelling a bit. The swelling was not life threatening or keeping from eating at this time. It was just uncomfortable to eat hard or salty foods. The outcome of the event was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: 6 Days after first dose- Rash on extremities; This is a spontaneous case from a contactable consumer (Patient) reported for himself that: A 58-years-old male patient received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 11:00 (Batch/Lot Number: EN6205) as DOSE 1, SINGLE for covid-19 immunization (Age at vaccination 58 years). The patient past medical history included Anemic from an unknown date and unknown if ongoing, Neuropathy peripheral from an unknown date and unknown if ongoing, High BP from an unknown date and unknown if ongoing and Borderline Diabetic from an unknown date and unknown if ongoing. There were no allergies reported. Concomitant medication included Gabapentin taken for an unspecified indication, start and stop date were not reported, Lisinopril taken for an unspecified indication, start and stop date were not reported, Atorvastatin taken for an unspecified indication, start and stop date were not reported and Allopurinol taken for an unspecified indication, start and stop date were not reported. Facility type vaccine: Pharmacy or drug store. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 02Mar2021,6 Days after first dose- Rash on extremities- following second shot came back worse- Almost 4 weeks after 2nd shot it appears to cover much more of my body and itches worse than any other time. AE resulted in doctor or other healthcare professional office/clinic visit. No treatment was reported. The event outcome was Not recovered.  The patient received 2nd Dose on 25Mar2021 bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8732, Expiry date: Unknown) via an unspecified route of administration, administered in Arm Left for COVID-19 immunization.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dry eye, Fatigue, Headache
Clinical narrative: Injection site pain; tiredness; headache; neck ache; muscle pain; chills; joint pain; fever; injection site redness; feeling unwell; dry eyes; swollen lymph nodes in armpits; tinnitus; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EW0169, and expiration date was not reported), via an unspecified route of administration, administered in left arm on 16Apr2021 at 09:45 (Age at vaccination was 45 years) as dose 2, single for covid-19 immunization. The patient medical history was reported as none. The patient did not have known allergies. The patient did not have covid prior to vaccination. There were no concomitant medications. The patient did not take any other vaccine in four weeks and any other medication in two weeks. Previously patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was ER8732, and expiration date were not reported), via an unspecified route of administration, administered in left arm, on 25Mar2021 at 09:45 hours (Age at vaccination was 45 years) as dose 1, single for COVID-19 immunization. On 16Apr2021 at 17:00 hours the patient experienced injection site pain, tiredness, headache, neck ache, muscle pain, chills, joint pain, fever, injection site redness, feeling unwell, dry eyes, swollen lymph nodes in armpits and tinnitus. The patient did not test covid post vaccination. Therapeutic measures were not taken for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Myalgia, Neck pain, Pyrexia
Clinical narrative: Injection site pain; tiredness; headache; neck ache; muscle pain; chills; joint pain; fever; injection site redness; feeling unwell; dry eyes; swollen lymph nodes in armpits; tinnitus; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EW0169, and expiration date was not reported), via an unspecified route of administration, administered in left arm on 16Apr2021 at 09:45 (Age at vaccination was 45 years) as dose 2, single for covid-19 immunization. The patient medical history was reported as none. The patient did not have known allergies. The patient did not have covid prior to vaccination. There were no concomitant medications. The patient did not take any other vaccine in four weeks and any other medication in two weeks. Previously patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was ER8732, and expiration date were not reported), via an unspecified route of administration, administered in left arm, on 25Mar2021 at 09:45 hours (Age at vaccination was 45 years) as dose 1, single for COVID-19 immunization. On 16Apr2021 at 17:00 hours the patient experienced injection site pain, tiredness, headache, neck ache, muscle pain, chills, joint pain, fever, injection site redness, feeling unwell, dry eyes, swollen lymph nodes in armpits and tinnitus. The patient did not test covid post vaccination. Therapeutic measures were not taken for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site pain; tiredness; headache; neck ache; muscle pain; chills; joint pain; fever; injection site redness; feeling unwell; dry eyes; swollen lymph nodes in armpits; tinnitus; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was EW0169, and expiration date was not reported), via an unspecified route of administration, administered in left arm on 16Apr2021 at 09:45 (Age at vaccination was 45 years) as dose 2, single for covid-19 immunization. The patient medical history was reported as none. The patient did not have known allergies. The patient did not have covid prior to vaccination. There were no concomitant medications. The patient did not take any other vaccine in four weeks and any other medication in two weeks. Previously patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number was ER8732, and expiration date were not reported), via an unspecified route of administration, administered in left arm, on 25Mar2021 at 09:45 hours (Age at vaccination was 45 years) as dose 1, single for COVID-19 immunization. On 16Apr2021 at 17:00 hours the patient experienced injection site pain, tiredness, headache, neck ache, muscle pain, chills, joint pain, fever, injection site redness, feeling unwell, dry eyes, swollen lymph nodes in armpits and tinnitus. The patient did not test covid post vaccination. Therapeutic measures were not taken for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Facial pain
Clinical narrative: discomfort to her her chest; pain to her face; This is a spontaneous report received from a contactable consumer (patient). A female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history of the patient were not reported. On an unspecified date, patient experienced discomfort to her chest and pain to her face after the first dose. Patient was scheduled for the second dose but cancelled it. Patient asked if still she can take the second dose of the vaccine as 7 weeks have passed since she received the first dose. Outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Blood thyroid stimulating hormone, Swelling, Tenderness, Ultrasound scan
Clinical narrative: swelling on L side of neck; tenderness over Thyroid mid and L side; This is a spontaneous report from a contactable other health care professional (patient). An elderly non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 06Feb2021 as dose 1, single for covid-19 immunization at hospital. The patient medical history included thyroiditis (25 years ago), inc BP, inc cholesterol, hypothyroid. Concomitant medications included atorvastatin, levothyroxine, lisinopril, all taken for unknown indications from an unknown date. Other medications received in two weeks included atorvastatin, levothyroxine, lisinopril. Patient did not receive any other vaccine in four weeks. It was reported that patient had no known allergies and was not to her knowledge. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 16 days after first Pfizer vaccine on 06Feb2021 developed swelling on L side of neck with some tenderness over Thyroid mid and L side. Saw PCP on 26Feb2021 and had thyroid tests that were WNL. Symptoms were resolving. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood work (blood test): unknown result on an unspecified date, thyroid tests (blood thyroid stimulating hormone): that were wnl on an unspecified date, ultrasound (ultrasound scan): unknown result on an unspecified date. Therapeutic measures were taken as a result of swelling on l side of neck, tenderness over thyroid mid and l side. OTC meds, blood work and ultrasound was received as treatment for adverse events. The outcome of the events was recovering.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache
Clinical narrative: she had joint pain for 1 day; chills for 1 week; headache; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 20Feb2021 (Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: not reported) administered on unspecified date for covid-19 immunisation. Reporter called on behalf of her mother. While gathering information she transferred the phone to her mother and stated that she got the 2nd dose of vaccine last 20Feb2021. The Patient reported she can't even remember the 1st dose date. She reported an adverse event after she got the 2nd dose until now. The patient experienced joint pain for 1 day, chills for 1 week on unspecified date. On 20Feb2021 patient experienced headache from the date of the 2nd dose until now. The patient reported she is taking herbal tea to lessen the pain. The patient wanted to know the reason why she is experiencing those. The outcome of the events Joint pain and chills was unknown while outcome of the event headache was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain, Pyrexia
Clinical narrative: headache; mild dizziness; body aches; mild fever; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 60-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0162, Expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 08Apr2021 12:00 (age at vaccination was 60 years) as dose 2, single for COVID-19 immunization. The patient's medical history was unknown. The patient did not have any known allergies. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: ER8727, Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on Mar2021 15:00 (age at vaccination was 60 years) as dose 1, single for COVID-19 immunization. After first dose patient experienced sore shoulder for 24 hours. On 09Apr2021 at 07:00, after second dose the patient experienced headache, mild dizziness, body aches and mild fever. No treatment was received for the adverse events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Feeling hot, Pain, Pyrexia
Clinical narrative: body aches; feeling very hot; fever of 101.8; cough; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 35 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 05Apr2021 08:45 (Batch/Lot Number: EW0150) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 15Mar2021 08:45 (Batch/Lot Number: EN6207) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medication(s) included ethinylestradiol, norgestimate (TRI-SPRINTEC) taken for contraception, start and stop date were not reported. The patient experienced body aches on 05Apr2021 16:00 with outcome of recovered, feeling very hot on Apr2021 with outcome of recovered, fever of 101.8 causing pyrexia on Apr2021 with outcome of recovered, cough on Apr2021 with outcome of recovered. The patient underwent lab tests and procedures which included body temperature at 101.8 on Apr2021 and sars-cov-2 test: positive on 26Mar2021 with Nasal swab.    No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: body aches; feeling very hot; fever of 101.8; cough; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 35 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 05Apr2021 08:45 (Batch/Lot Number: EW0150) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 15Mar2021 08:45 (Batch/Lot Number: EN6207) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medication(s) included ethinylestradiol, norgestimate (TRI-SPRINTEC) taken for contraception, start and stop date were not reported. The patient experienced body aches on 05Apr2021 16:00 with outcome of recovered, feeling very hot on Apr2021 with outcome of recovered, fever of 101.8 causing pyrexia on Apr2021 with outcome of recovered, cough on Apr2021 with outcome of recovered. The patient underwent lab tests and procedures which included body temperature at 101.8 on Apr2021 and sars-cov-2 test: positive on 26Mar2021 with Nasal swab.    No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Dysstasia
Clinical narrative: sore arm; fever; chills; diarrhea; nausea; muscle aches; feeling weak; tired; dizzy; unable to stand; This is a spontaneous report from a contactable consumer (patient) reported that:   A 39-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Er8731), via an unspecified route of administration, administered in Arm Right on 14Apr2021 11:00AM (At the age of 39 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously  received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Er8727), via an unspecified route of administration, administered in Arm Right on 24Mar2021 (At the age of 39 years) as DOSE 1, SINGLE for covid-19 immunisation and later experienced light headed and sore arm. Patient was not pregnant at the time of vaccination. Medical history included anemia from an unknown date and unknown if ongoing. The patient took other medications in two weeks like, Iron supplement, birth control. Patient was allergies to doxycycline. The patient experienced sore arm, fever (24Hours), chills, diarrhea, nausea, muscle aches, feeling weak, tired, dizzy, unable to stand on 14Apr2021 18:00. Yes, drug Ibuprofen was received in response to adverse event as treatment. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. On15Apr2021 18:00, the event fever was recovered. At the time of reporting, the outcome of the events sore arm, chills, diarrhea, nausea, muscle aches, feeling weak, tired, dizzy, unable to stand were recovering.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: sore arm; fever; chills; diarrhea; nausea; muscle aches; feeling weak; tired; dizzy; unable to stand; This is a spontaneous report from a contactable consumer (patient) reported that:   A 39-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Er8731), via an unspecified route of administration, administered in Arm Right on 14Apr2021 11:00AM (At the age of 39 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously  received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Er8727), via an unspecified route of administration, administered in Arm Right on 24Mar2021 (At the age of 39 years) as DOSE 1, SINGLE for covid-19 immunisation and later experienced light headed and sore arm. Patient was not pregnant at the time of vaccination. Medical history included anemia from an unknown date and unknown if ongoing. The patient took other medications in two weeks like, Iron supplement, birth control. Patient was allergies to doxycycline. The patient experienced sore arm, fever (24Hours), chills, diarrhea, nausea, muscle aches, feeling weak, tired, dizzy, unable to stand on 14Apr2021 18:00. Yes, drug Ibuprofen was received in response to adverse event as treatment. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. On15Apr2021 18:00, the event fever was recovered. At the time of reporting, the outcome of the events sore arm, chills, diarrhea, nausea, muscle aches, feeling weak, tired, dizzy, unable to stand were recovering.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, SARS-CoV-2 test
Clinical narrative: First shot was pretty normal, but also hollow chest feeling.; This is a spontaneous report from a contactable consumer (patient). A 48 years old non- pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6208, Expiry date was not reported) via an unspecified route, administered in Arm Left on 13Mar2021 at 12:15 (at the age of 48 years old) as Dose 1, Single for Covid-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history and concomitant medications within 2 weeks of vaccination were not reported. No known allergies were reported. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient did not received any other vaccine within 4 weeks. The reporter stated that, first shot was pretty normal, but also hollow chest feeling on 03Apr2021. The patient did not receive any treatment medication for resulted event. The patient underwent lab tests and procedures which included SARS-CoV-2 test negative on 29Mar2021. The outcome for the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Erythema, Fatigue, Limb discomfort
Clinical narrative: Weakness; Severe diarrhea lasting for two and a half days; Severe fatigue; Heaviness of limbs; Severe itching; Redness; Swelling on upper back; This is a spontaneous report from a contactable consumer (patient). A 56-years-old nonpregnant female patient received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: ER8729), via an unspecified route of administration, administered in Arm Left on 16Apr2021 03:00 (at the age of 56 years old) as single dose for covid-19 immunisation. Medical history included, sleep apnoea syndrome, depression from an unknown date and unknown if ongoing. The patient had seasonal allergies, Pine tree allergy, seafood sensitivity from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication(s) included Wellbutrin, celexa, levothyroxine, Diuretic taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: EN6208) in left arm on 25Mar2021 03:00PM (at the age of 56 years old) for covid-19 immunisation. On 16Apr2021 12:30 , the patient experienced severe itching , redness , swelling on upper back. severe fatigue, heaviness of limbs on 16Apr2021 18:30. Weakness, severe diarrhoea lasting for two and a half days, on 17Apr2021 10:30. Benadryl were taken as a result of severe itching. The outcome of severe itching, redness , swelling on upper back, Weakness, severe fatigue, heaviness of limbs was recovering and diarrhoea lasting for two and a half days was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling
Clinical narrative: Weakness; Severe diarrhea lasting for two and a half days; Severe fatigue; Heaviness of limbs; Severe itching; Redness; Swelling on upper back; This is a spontaneous report from a contactable consumer (patient). A 56-years-old nonpregnant female patient received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: ER8729), via an unspecified route of administration, administered in Arm Left on 16Apr2021 03:00 (at the age of 56 years old) as single dose for covid-19 immunisation. Medical history included, sleep apnoea syndrome, depression from an unknown date and unknown if ongoing. The patient had seasonal allergies, Pine tree allergy, seafood sensitivity from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication(s) included Wellbutrin, celexa, levothyroxine, Diuretic taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: EN6208) in left arm on 25Mar2021 03:00PM (at the age of 56 years old) for covid-19 immunisation. On 16Apr2021 12:30 , the patient experienced severe itching , redness , swelling on upper back. severe fatigue, heaviness of limbs on 16Apr2021 18:30. Weakness, severe diarrhoea lasting for two and a half days, on 17Apr2021 10:30. Benadryl were taken as a result of severe itching. The outcome of severe itching, redness , swelling on upper back, Weakness, severe fatigue, heaviness of limbs was recovering and diarrhoea lasting for two and a half days was recovered.   No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal eruption, Rash, Rash pruritic
Clinical narrative: Rash ended up on mouth; Painful rash on jaw./ Rash ended up on neck/ Rash began on sides of face; Itchy rash on jaw./ Rash ended up on neck/ Rash began on sides of face; Itchy rash on jaw./ Rash ended up on neck/ Rash began on sides of face; This is a spontaneous case from a contactable consumer(patient) reported that. A 17-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection), dose 1 via an unspecified route of administration on 13Apr2021 09:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization (Age at vaccination 17 years).The patient medical history was reported as none. The patient had no allergies to medications, food or other products.The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:00, the patient experienced painful and itchy rash on jaw. It began on sides of face and had ended up on neck and mouth.Therapeutic measures were taken as a result of events and included treatment with Benadryl and topical Benadryl. It was reported that rash was not lessened by Benadryl. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful and itchy rash on jaw which began on sides of face and had ended up on neck and mouth was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: chills; low grade fever; aches; nausea; vertigo; dizzy; hollow tunnel feeling; vibration feeling under skin; fatigue; brain fog; confusion; verbal errors; This is a spontaneous report from a contactable consumer (patient herself). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0151, expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 02Apr2021 13:15 (age at the time of vaccination was 48-year-old) as dose 2, single for COVID-19 immunization in hospital. The patient's medical history was not reported. The patient's concomitant medications were not reported. Patient had no covid prior vaccination. Historical vaccine includedBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6208, expiration date: not reported), via an unspecified route of administration, administered in the left arm on 13Mar2021 at 12:15 as dose 1, single for COVID-19 immunization. Patient had no other vaccine in four weeks. On 03Apr2021, the patient experienced chills, low grade fever, aches, nausea, vertigo, dizzy, hollow tunnel feeling, vibration feeling under skin, fatigue, brain fog, confusion, verbal errors. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 29Mar2021. Patient had no treatment for the events. Clinical outcome of the events was reported as not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, SARS-CoV-2 test, Skin disorder
Clinical narrative: chills; low grade fever; aches; nausea; vertigo; dizzy; hollow tunnel feeling; vibration feeling under skin; fatigue; brain fog; confusion; verbal errors; This is a spontaneous report from a contactable consumer (patient herself). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0151, expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 02Apr2021 13:15 (age at the time of vaccination was 48-year-old) as dose 2, single for COVID-19 immunization in hospital. The patient's medical history was not reported. The patient's concomitant medications were not reported. Patient had no covid prior vaccination. Historical vaccine includedBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6208, expiration date: not reported), via an unspecified route of administration, administered in the left arm on 13Mar2021 at 12:15 as dose 1, single for COVID-19 immunization. Patient had no other vaccine in four weeks. On 03Apr2021, the patient experienced chills, low grade fever, aches, nausea, vertigo, dizzy, hollow tunnel feeling, vibration feeling under skin, fatigue, brain fog, confusion, verbal errors. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 29Mar2021. Patient had no treatment for the events. Clinical outcome of the events was reported as not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Vertigo
Clinical narrative: chills; low grade fever; aches; nausea; vertigo; dizzy; hollow tunnel feeling; vibration feeling under skin; fatigue; brain fog; confusion; verbal errors; This is a spontaneous report from a contactable consumer (patient herself). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0151, expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 02Apr2021 13:15 (age at the time of vaccination was 48-year-old) as dose 2, single for COVID-19 immunization in hospital. The patient's medical history was not reported. The patient's concomitant medications were not reported. Patient had no covid prior vaccination. Historical vaccine includedBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6208, expiration date: not reported), via an unspecified route of administration, administered in the left arm on 13Mar2021 at 12:15 as dose 1, single for COVID-19 immunization. Patient had no other vaccine in four weeks. On 03Apr2021, the patient experienced chills, low grade fever, aches, nausea, vertigo, dizzy, hollow tunnel feeling, vibration feeling under skin, fatigue, brain fog, confusion, verbal errors. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 29Mar2021. Patient had no treatment for the events. Clinical outcome of the events was reported as not recovered.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: pain in arm pit; swelling; This is a spontaneous report from a Pfizer-sponsored program via contactable consumer (patient).  A female patient of an unspecified age received first dose of BNT162B2 (PFIZ-ER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as dose 1, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had 1st dose of covid vaccine Monday and on an unspecified date having side effects not going away, such as pain in arm pit and swelling. The patient was wondering what she could do for side effects and will they go away. Outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hepatic pain, Loss of personal independence in daily activities, Malaise, Nausea
Clinical narrative: pain in the liver; not feeling well: he has nausea, headache, pain in the kidney and liver, vomiting.; nausea; headache; vomiting; pain in the kidney; not been able to go to work in 4 days; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on 14Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that he got the first dose of the Pfizer covid vaccine on Wednesday 14Apr2021 and since that week he had been not feeling well he had nausea, headache, pain in the kidney and liver, vomiting. He said that he cannot tolerate food and water and throws them up. He felt so bad that he had not been able to go to work in 4 days and he had gone to 2 different hospitals but not one doctor was able to prescribe anything since they don't know what he had. He just wanted to report his side effects and get some help to get his health back. The outcome of all the events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Renal pain, Vomiting
Clinical narrative: pain in the liver; not feeling well: he has nausea, headache, pain in the kidney and liver, vomiting.; nausea; headache; vomiting; pain in the kidney; not been able to go to work in 4 days; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on 14Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that he got the first dose of the Pfizer covid vaccine on Wednesday 14Apr2021 and since that week he had been not feeling well he had nausea, headache, pain in the kidney and liver, vomiting. He said that he cannot tolerate food and water and throws them up. He felt so bad that he had not been able to go to work in 4 days and he had gone to 2 different hospitals but not one doctor was able to prescribe anything since they don't know what he had. He just wanted to report his side effects and get some help to get his health back. The outcome of all the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pruritus, Vaccination site pain
Clinical narrative: nausea; injection site pain; itchiness; underarm pain; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration in left arm on 24Mar2021 at 12:15 (at the age of 40-year-old) as single dose for COVID-19 immunization. Patient did not receive any other medications in two weeks or any other vaccine in four weeks. Patient had no covid prior vaccination and was not tested for COVID post vaccination. Patient previously received took Keflexen and experienced allergy. On 24Mar2021 at 20:00 the patient experienced nausea, injection site pain and itchiness and underarm pain. Patient did not receive any treatment in response to the event. Outcome of the events were recovered.  No follow-up attempts are required; information about lot/batch number cannot been obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Feeling abnormal, Nausea
Clinical narrative: Fever 100 degree 3 days; Nausea; Vomiting feeling; Tiredness; Dizziness; Injection site pain; Foggy head; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ER8734), via an unspecified route of administration on arm left on 13Apr2021 14:30 (age at vaccination: 33 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included Hypothyroidism. It was unknown whether patient had allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient Concomitant medications in two weeks included Ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication from an unknown date. Other vaccine in four weeks was reported as no.The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: unknown), dose 1 via an unspecified route of administration on left arm on 15Mar2021 09:30 AM (at the age of 33 years) as DOSE 1, SINGLE for COVID-19 immunisation and experienced mild fever. On 14Apr2021 01:00 PM, the patient experienced Fever 100 degree 3 days, Nausea, Vomiting feeling, Tiredness, Dizziness, Injection site pain , Foggy head. The lab test included Body temperature: 100 degree(Fever 100 degree 3 days) on an unspecified date. Therapeutic measures were not taken as a result of events. The outcome of events was not resolved. No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Fever 100 degree 3 days; Nausea; Vomiting feeling; Tiredness; Dizziness; Injection site pain; Foggy head; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ER8734), via an unspecified route of administration on arm left on 13Apr2021 14:30 (age at vaccination: 33 years) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included Hypothyroidism. It was unknown whether patient had allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient Concomitant medications in two weeks included Ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication from an unknown date. Other vaccine in four weeks was reported as no.The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: unknown), dose 1 via an unspecified route of administration on left arm on 15Mar2021 09:30 AM (at the age of 33 years) as DOSE 1, SINGLE for COVID-19 immunisation and experienced mild fever. On 14Apr2021 01:00 PM, the patient experienced Fever 100 degree 3 days, Nausea, Vomiting feeling, Tiredness, Dizziness, Injection site pain , Foggy head. The lab test included Body temperature: 100 degree(Fever 100 degree 3 days) on an unspecified date. Therapeutic measures were not taken as a result of events. The outcome of events was not resolved. No follow-up attempts are possible. No further information is expected.